Ayşe Betül Öztürk

Ayşe Betül Öztürk

Auto-generated profile, based on publicly available information

Ayşe Betül Öztürk

Muş Public Hospital

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
SESelçuk Erkılınç
Selçuk Erkılınç
SÖSena Özcan
Sena Özcan
AÖAyşe Betül Öztürk
Ayşe Betül Öztürk
SISerhan Can İşCan
Serhan Can İşCan
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
İÇİlker Çakır
İlker Çakır
SUMMARY OBJECTIVE: The objective of the study was to evaluate perioperative and oncologic outcomes of laparoscopy without the use of uterine manipulators and laparotomy in high-grade and serous endometrial cancer. METHODS: Patients with grade III endometrioid adenocarcinoma and serous carcinoma between 2018 and 2022 were included in the study. Preoperative staging with positron emission tomography/computed tomography or thoracoabdominal computed tomography and pelvic magnetic resonance imaging was performed. All patients underwent staging surgery including hysterectomy, bilateral salpingo-oophorectomy, peritoneal washing, omentectomy, and pelvic and paraaortic lymphadenectomy up to the renal vein. No uterine manipulator was used for laparoscopic hysterectomy. Age, CA 125 level, body mass index, accompanying diseases, pathologic data including stage, lymphovascular invasion, number of pelvic and paraaortic lymph nodes, and surgical data including surgical time, surgical complications, and adjuvant therapies were collected from the hospital database retrospectively. RESULTS: Notably, 89 patients were included in the study: 34 underwent laparotomy and 55 underwent laparoscopy. Surgical times were similar between the groups. The mean pelvic lymph node count in the laparotomy and laparoscopy groups was 33 and 34, respectively. The mean paraaortic lymph node counts in the laparotomy and laparoscopy groups were 23 and 22, respectively. Red blood cell transfusion, hemorrhage, urinary tract infection, postoperative fever, bladder atony, bladder injury, and chylous leakage showed no significant differences between the groups. However, ileus, intestinal injury, and evisceration were significantly higher in the laparotomy group. Hospital stay was significantly longer in the laparotomy group compared with the laparoscopy group. Overall and recurrence-free survival were similar between the groups. CONCLUSION: Laparoscopic surgery, performed without manipulators, provides comparable oncologic outcomes to open surgery in the treatment of high-grade endometrial cancer, while also offering improved perioperative results.

28 February 2025 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
SESelçuk Erkılınç
Selçuk Erkılınç
SISerhan Can İşCan
Serhan Can İşCan
SÖSena Özcan
Sena Özcan
BÖBetül Öztürk
Betül Öztürk
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
İÇİlker Çakır
İlker Çakır
Undefined - Turkish Journal of Obstetrics and Gynecology

22 March 2025 in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Verified
Journal Article
Open access
PDF file
SESelçuk Erkılınç
Selçuk Erkılınç
SÖSena Özcan
Sena Özcan
AÖAyşe Betül Öztürk
Ayşe Betül Öztürk
SISerhan İsCan
Serhan İsCan
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
İÇİlker Çakır
İlker Çakır
Background and Aim: To evaluate the intraoperative and postoperative outcomes of the patients underwent interval cytoreduction and hypertermic intraperitoneal chemotherapy Methods This retrospective study included 23 patients who underwent cytoreductive surgery with HIPEC for high-grade serous ovarian cancer between December 2021 and September 2023 at our gynecologic oncology unit. HIPEC was performed using cisplatin at a dose of 100 mg/m², with continuous perfusion at 42°C for 90 minutes. Clinical characteristics, including age, comorbidities, preoperative CA-125 levels, and surgical details, were collected. Intraoperative parameters such as the extent of resection, anesthesia duration, transfusions, and urine output were analyzed. Postoperative complications, including acute renal insufficiency (ARI), were evaluated using daily creatinine measurements. Statistical analyses were conducted using SPSS 25, with continuous variables presented as mean ± standard deviation or median (range). Results The mean age of patients was 61 ± 10 years, and 78.6% were postmenopausal. The median gravida and parity were 3 (range: 2–7). 69.6% had ascites, with a median volume of 1000 mL (0–3000 mL). The median peritoneal carcinomatosis index (PCI) score was 14 (6–28). Neoadjuvant chemotherapy was administered to 91.3% of patients, with a median interval of 31.6 ± 4.6 days between NACT and surgery. The most common procedures performed included omentectomy (100%), colonic resection (13%), small bowel resection (8.7%), and splenectomy (21.7%). The median operation time was 316 minutes, and the median intraoperative bleeding was 400 mL (300–1000 mL). Postoperatively, the median hospital stay was 10 days (5–19). Acute renal insufficiency (ARI) occurred in 21% of patients, while other complications included ileus (13%), wound infection (17%), and atelectasis (21%). Median creatinine levels were 0.8 mg/dL on Postoperative Day 1, 1.1 mg/dL on Postoperative Day 2, and 0.9 mg/dL on Postoperative Day 3, indicating a transient postoperative rise in renal dysfunction. Notably, all patients who required renal replacement therapy had received cisplatin-based HIPEC at a dose of 100 mg/m². The median urine output during HIPEC was 400 mL, suggesting the need for close renal monitoring. Conclusion Cytoreductive surgery with HIPEC in ovarian cancer is a feasible option for advanced ovarian cancer with acceptable renal and surgical morbidity